Abstract:Abstract Background The treatment of complex diseases by taking multiple drugs becomes increasingly popular. However, drug-drug interactions (DDIs) may give rise to the risk of unanticipated adverse effects and even unknown toxicity. DDI detection in the wet lab is expensive and time-consuming. Thus, it is highly desired to develop the computational methods for predicting DDIs. Generally, most of the existing computational methods predict DDIs by extracting the chemical and biological features of drugs from diverse drug-related properties, however some drug properties are costly to obtain and not available in many cases. Results In this work, we presented a novel method (namely DPDDI) to predict DDIs by extracting the network structure features of drugs from DDI network with graph convolution network (GCN), and the deep neural network (DNN) model as a predictor. GCN learns the low-dimensional feature representations of drugs by capturing the topological relationship of drugs in DDI network. DNN predictor concatenates the latent feature vectors of any two drugs as the feature vector of the corresponding drug pairs to train a DNN for predicting the potential drug-drug interactions. Experiment results show that, the newly proposed DPDDI method outperforms four other state-of-the-art methods; the GCN-derived latent features include more DDI information than other features derived from chemical, biological or anatomical properties of drugs; and the concatenation feature aggregation operator is better than two other feature aggregation operators (i.e., inner product and summation). The results in case studies confirm that DPDDI achieves reasonable performance in predicting new DDIs. Conclusion We proposed an effective and robust method DPDDI to predict the potential DDIs by utilizing the DDI network information without considering the drug properties (i.e., drug chemical and biological properties). The method should also be useful in other DDI-related scenarios, such as the detection of unexpected side effects, and the guidance of drug combination.

What problem does this paper attempt to address?

The paper aims to address the problem of Drug-Drug Interactions (DDIs) prediction. Specifically, the main objectives of the study include: 1. **Developing new computational methods**: A novel computational method called DPDDI (Deep Predictor for Drug-Drug Interactions) has been developed for DDI prediction. This method can extract the network structural features of drugs from the drug interaction network. 2. **Utilizing Graph Convolution Network**: By using Graph Convolution Network (GCN) to learn the low-dimensional feature representation of drugs in the DDI network, this method does not rely on the chemical or biological properties of the drugs. 3. **Improving prediction performance**: Compared to several existing advanced methods, DPDDI shows better performance in DDI prediction. This is mainly due to the fact that the features extracted by GCN from the DDI network contain more DDI information than those extracted from chemical, biological, or anatomical attributes. 4. **Addressing data imbalance issue**: The study also explores the impact of the positive and negative sample ratio on prediction performance and proposes a weight adjustment strategy to alleviate the sample imbalance problem. 5. **Case study validation**: Through case studies of the prediction results, it is confirmed that DPDDI is effective in predicting new DDIs, particularly in discovering potential adverse reactions and guiding drug combinations. In summary, the goal of this study is to develop an efficient and robust DDI prediction tool to assist in the design of multi-drug treatment regimens during drug development, thereby reducing the risk of side effects caused by DDIs.

DPDDI: a deep predictor for drug-drug interactions

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

Deep learning for drug‐drug interaction prediction: A comprehensive review

Directed graph attention networks for predicting asymmetric drug–drug interactions

DSN-DDI: an accurate and generalized framework for drug–drug interaction prediction by dual-view representation learning

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks

Drug-Drug Interaction Predicting by Neural Network Using Integrated Similarity

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge

Predicting drug–drug interactions by graph convolutional network with multi-kernel

Enhancing drug–drug interaction prediction by three-way decision and knowledge graph embedding

DDI‐Transform: A neural network for predicting drug‐drug interaction events

Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

Prediction of multiple types of drug interactions based on multi-scale fusion and dual-view fusion

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions

Molecular Substructure-Aware Network With Reinforcement Pooling and Deep Attention Mechanism for Drug-Drug Interaction Prediction